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Objective: We aimed to achieve accurate statistical modeling of a putative relationship between carotid endarterectomy
(CEA) annual surgeon and hospital volume and in-hospital mortality.
Design of Study: We performed a secondary data analysis of 10 years (1994-2003) of the Maryland hospital discharge
database. Annual volume was defined as the total number of procedures performed for the time in the dataset divided by
the total years in the dataset. Non-linear relationships between death and average volumes were explored with
logit-transformed lowess smoothing functions, followed by random effect models and inspection of data likelihood under
each combination of spline knots. A marginal model with generalized estimating equations was used to represent
population-average response as a function of covariates and to account for clustering in the data. Patient comorbidity was
assessed using the Deyo modification of the Charlson Index.
Setting: The Maryland hospital discharge database is a 100% sample of all hospitals in the state.
Subjects: CEA was identified through ICD-9 and diagnosis codes, using a previously reported algorithm.
Main Outcome Measure: Estimated odds ratios predicting in-hospital death,  set at 0.05.
Results:During the study period, 22,772 patients with surgeon identifiers underwent CEA inMaryland, resulting in 123
in-hospital deaths (0.54%). The crude odds ratio of death for the entire surgeon dataset was 0.9838, meaning that the
odds of death decreased by an average of 0.0162 for each additional annual procedure. Surgeon volume of four to 15
CEAs per year was highly significant: for an increase in annual surgeon volume by one procedure per year, the estimated
odds of death decreased by 0.065 when controlling for hospital volume, age, and comorbidity (P  .351). Surgeons in
other volume categories also demonstrated lower odds of death with increased annual volume, but these odds ratios did
not attain statistical significance. Surgeons performing <3 CEA per year had an odds ratio of death of 0.802 per
additional annual procedure (P  .351), whereas those performing >15 CEAs per year had an odds ratio of 0.997 (P 
.485). Hospitals that saw >130 CEAs per year had an odds ratio of death of 0.945 per additional procedure, or 0.055
decrease in the odds of death (P 0.013), whereas hospitals performing<130 CEAs per year had an odds ratio of 0.998
(P  0.563).
Conclusion: We have demonstrated a technique for rigorous statistical analysis of volume-outcome data and have found
a volume effect for death after CEA in this 10-year Maryland dataset. Higher volume surgeons had lower estimated odds
of death, particularly those performing four to 15 CEAs per year. These data suggest that a patient undergoing CEA by
a surgeon performing an average of 16 CEAs annually has a statistically equivalent risk of death compared with one
undergoing CEA by a surgeon performing any number higher than this, when controlling for hospital volume, patient
comorbidity, and patient age. Hospital volume was not seen to be as significant a predictor of postoperative death in this
study, with only high volume hospitals (>130 CEAs per year) showing a statistically significant decrease in the odds ratio of
death. As studies on volume-outcome relationships can have important implications for health policy and surgical training,
such studies should consider non-linear effects in their modeling of procedural volume. (J Vasc Surg 2008;48:343-50.)From the Department of Surgerya and the Bloomberg School of Public
Health,b Johns Hopkins University.
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doi:10.1016/j.jvs.2008.03.033Carotid endarterectomy (CEA) remains one of the
most common vascular surgical procedures in the United
States. More than 50 years after its implementation by
Eastcott and Robb, CEA remains the “gold standard”
treatment for carotid artery disease.1-3 The predominance
of this procedure has been established by numerous studies
demonstrating its safety and efficacy. The North American
Symptomatic Carotid Endarterectomy Trial (1991)4 and
The Asymptomatic Carotid Atherosclerosis Study (1995)5
supported the superiority of the CEA over the best medical
management of patients with50% symptomatic or60%
asymptomatic carotid stenoses, respectively.
Despite the proven efficacy of this procedure, questions
remain as to whether all patients have access to the high
quality surgeons and hospitals reflected in these and other
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eases support the notion that “practice makes perfect”:
those surgeons or hospitals performing the greatest number
of surgeries yearly provide the best outcomes.6-17 Numerous
studies of CEA have established tiers of surgeons or hospitals
performing low-, middle-, and high-numbers of CEAs per
year and demonstrated differences in outcomes among
these strata.15,18-24 Using this evidence, practitioners and
health policymakers have argued that higher volume sur-
geons and hospitals render superior CEA results to pa-
tients, leading to calls for regionalization of CEA care.25-27
To date, investigators of the volume-outcome relation-
ship for CEA surgery have arrived at their thresholds for
high-, medium-, and low-volume surgeons and hospitals
either empirically or based on quantiles.18-22,24,28 While
many authors have found a volume effect for CEA, their
wide-ranging definitions for volume categories makes it
difficult to effect definitive policy changes or for patients to
know what annual surgical volume does make a difference
to their outcome.
We hypothesized that we could establish evidence-
guided volume guidelines for hospital and surgeon volume
using standard statistical techniques. By allowing the data
of 10 years of the Maryland hospital discharge database to
drive the analysis, we hypothesized that we could find the
best-supported volume categories for CEA. Furthermore,
we hypothesized that a model including other covariates
such as age, race, gender, and comorbidities would estab-
lish the relative contribution of surgeon and hospital vol-
ume compared with these other factors. Because of the
state-specific nature of our dataset, our hypotheses focused
on the effects of recent surgeon and hospital experience,
rather than “lifetime” experience.
MATERIALS AND METHODS
The present study was a secondary data analysis of 10
years (1994-2003) of the Maryland Health Services Cost
Review Commission (HSCRC) database. Established in
1971 by the Maryland legislature, this organization aims
primarily to contain rising medical costs. In the process, the
HSCRC collects extensive information on all patients and
medical procedures occurring within the state of Maryland.
We analyzed the HSCRC dataset over the abovementioned
10-year period, using a previously reported algorithm to
identify 22,772 patients undergoing CEA.29-31 Patients
with all three of the following diagnoses were included: 1)
International Classification of Diseases, 9th Revision, Clin-
ical Modification (ICD-9-CM) procedure code 38.12
(endarterectomy of the vessels of the head and neck other
than intracranial vessels) in the primary coding position but
not in any secondary position, and 2) Diagnosis-Related
Group (DRG) 5 (extracranial vascular procedure), and
3) Diagnosis code 433.00 to 433.91 (occlusion/stenosis,
precerebral artery). The accuracy of this algorithm was
confirmed through a previously published chart review, in
which the presence of all three of the abovementioned
codes was required to achieve 100% correct identification of
CEA patients.29 Patients receiving CEA concurrently withanother procedure, such as coronary artery bypass grafting,
were not included in this analysis, based on the previous
performance of the algorithm.
We analyzed the relationship between in-hospital death
and annual surgeon and hospital volume. Annual surgeon
volume was defined by the total number of procedures
performed by a surgeon for their total time within the
dataset divided by the number of years the surgeon was
included in the dataset. Thus a surgeon who was included
in the dataset for only five years would have an average
volume that could be compared with any other surgeon
who was included for any amount of time between one and
ten years.
Crude odds ratios of death were first determined by
logistic regression for annual surgeon volume and annual
hospital volume. Heterogeneity by calendar year was ex-
plored by performing the analysis within each year. Non-
linear relationships between death and average annual sur-
geon and hospital volume were explored by examining
logit-transformed lowess smoothing functions. A lowess
smoothing function facilitates visual inspection of the data
as well as quantitative assessment by fitting a weighted
linear least squares regression over small localized segments
of the data. Thus a scatterplot of data is rendered more
visually accessible by the superimposition of a smooth line
that can reflect slope changes across the range of the
explanatory variable. If the lowess smoothed line has a
natural inflection point (ie visually noticeable change in the
slope), the investigator can then elect to treat different
ranges of the explanatory variable individually in the anal-
ysis, by allowing the slope to change over the range of the
variable. In other words, an inflection point (known as a
“knot” statistically) can be used to demarcate two different
slopes in the regression. Since the outcome of our analysis
was odds of death, we used a curve smoothed by log odds
(“logit”).32 Rough identification of spline knots from the
plots was followed by using random effect models and
inspecting likelihood of the data under each combination
of spline knots. When various combinations of knots appear
possible from preliminary visual inspection of the data, the
investigator may wish to weigh the explanatory power of
including all possible knots versus more parsimonious
models including only a subset of knots. Random effects
models allow each subject (each surgeon in this case) to
have a different intercept such that minimal assumptions
are made about correlations between surgeons. Consider-
ation was given to other values around the knots initially
identified, 5 CEAs per year. This exploration of values
around the knots identified by visual inspection was done to
ensure that the best value had been chosen in terms of its
explanatory power. A functional form for age was similarly
determined by inspection of logit transformed lowess
smoothed plots.
Analysis proceeded similarly for looking at hospital
volumes. Annual average hospital volume was defined anal-
ogously as for annual average surgeon volume: number of
procedures performed in the hospital in the complete
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was included in the dataset.
The effect of patient co-morbidity was determined
through use of unweighted Charlson comorbidities.33 The
Charlson Index was developed in 1987 as a way to com-
municate the risk profile of a patient by pooling weighted
values for selected conditions. The weights and chosen
comorbidites were developed by Charlson et al using an
inpatient cohort of 604 patients admitted to the medical
service of New York Hospital. We chose to disregard the
weights in the present study, instead using the number of
Charlson comorbidities as identified by ICD-9-CM codes
in the dataset, per Deyo.34 The list of comorbidities is as
follows:
Myocardial infarct Hemiplegia
Congestive heart failure Moderate or severe renal disease
Peripheral vascular disease Diabetes with end organ damage
Cerebrovascular disease Any tumor
Dementia Leukemia
Chronic pulmonary disease Lymphoma
Connective tissue disease Moderate or severe liver disease
Ulcer disease Metastatic solid tumor
Mild liver disease AIDS
Diabetes
Adapted from.33
Patients with3 Charlson comorbidities were used as a
reference in comparison with patients with one or two
comorbidities for association with risk of death.
A marginal model with generalized estimating equa-
tions (GEE) was used to represent the population-average
response as a function of covariates and to account for
clustering in the data. Clustering was accounted for only at
the surgeon level, not hospital.
All measures of statistical significance were based on
  0.05. Stata SE, version 10, from Stata Corporation
(College Station, Tex) was used for data analysis. The final
model employed general estimating equations using ex-
changeable correlation.
RESULTS
From 1994-2003, CEA was performed on 22,772
patients in Maryland, in 47 hospitals by 442 surgeons. This
sample consisted of 54.7% men and 45.3% women, ranging
in age from 33-99 years (mean, 70.6 years). The vast
majority of the patients were white (21,229 or 91.4%);
1,682 were black (7.2%). There were 123 in-hospital
deaths (0.54%) over this 10-year period among those with
surgeon identifiers.
Examination of the histogram of average annual sur-
geon volume demonstrates a strong predominance of low-
volume surgeons (Fig 1). This distribution of CEAs among
surgeons follows a roughly inverse power relationship, with
214 of the surgeons (48.42%) performing an average of
only one CEA per year.
The crude odds ratio of death for the entire surgeon
dataset was 0.9838, meaning that the odds of death de-creased by an average of 0.0162 for each additional annual
procedure.
The possibility of heterogeneity of volume effect by
calendar year was considered. However, since the number
of observations (deaths following CEA) per calendar year
was small, it was not possible to detect heterogeneity if it
did exist. For the interpretation of this study, we assumed
homogenous effect of surgeon volume on death over cal-
endar years.
Examination of the logit (log-odds) transformed low-
ess smoothed functions suggested three knots for surgeon
volume: around five CEAs per year, 20 CEAs per year, and
35 CEAs per year. (Fig 2). Using random effects models we
examined log likelihoods of different models around these
knots (i.e. 3, 4, 5, 15-25, 30-40, etc.) and found the
highest log likelihood to be rendered by knots at 3 CEAs
per year and 15 CEAs per year. Despite the suggestion of a
knot around 35 CEAs per year, the P value for this knot was
not significant. The lowess smoothed plot for patient age
Fig 1. Histogram demonstrating the distribution of annual CEA
volume among the surgeons in the dataset.
Fig 2. Logit transformed lowess smoothed curve of annual CEA
surgeon volume.clearly suggested an inflection at 60 years, a value that was
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around 60 years. Patients over age 60 comprised 85.96% of
the sample.
In analysis of hospital volume, a high proportion of
low-volume hospitals was again noted in histogram analysis
(Fig 3). Examination of the logit transformed smooth
curve suggested two splines at annual hospital volume of 25
CEAs per year and 130 CEAs per year (Fig 4). Examination
of values around 25 CEAs per year did not support inclu-
sion of this knot in the model, but the knot at 130 CEAs per
year was retained due to statistical significance.
This final model was used to predict the odds of in-
hospital death following CEA:
log it(deathij) 0 1(surgeonvolume)
 2(surgeonvolume)3  3(surgeonvolume)15
 4(hosptialvolume) 5(hosptialvolume)130
 6(age) 7(age)60 8(1comorbidity)
Fig 3. Histogram demonstrating the distribution of annual CEA
volume among the hospitals in the dataset.
Fig 4. Logit transformed lowess smoothed curve of annual CEA
hospital volume. 9(2comorbidities)Logistic regression rendered the following point esti-
mates, 95% confidence estimates and P values (Table I). As
can be seen in the bolded values, surgeon volume of four to
15 CEAs per year was highly significant with respect to
odds of death. For an increase in annual surgeon volume by
one procedure per year, the odds of death decreased by
0.065 when controlling for hospital volume, age and num-
ber of Charlson comorbidities. In other words, a patient
whose surgeon performs six CEAs per year would be ex-
pected to have 0.935 the odds of death of a patient whose
surgeon performs five CEAs per year, averaged across the
population. The same inference can be drawn for any one
CEA per year difference in annual surgeon volume in this
volume range of four to 15 CEAs per year. Hospitals that
saw 130 CEAs per year had an odds ratio of death of
0.945 per additional procedure annually (P  .013), or
0.055 decrease in the odds of death. The impact of each
additional year of age on odds of death after CEA was
U-shaped. For each additional year in age for those 60
years, the odds ratio per year of age was 0.936, but statis-
tically non-significant (P  .115). However, patients 60
years had an odds ratio of death of 1.058 per additional year
of age (P  .0001). Finally, the number of Charlson
comorbidities was highly significant, with each additional
comorbidity adding significantly to the odds of death after
CEA. Those with a single Charlson comorbidity had an
odds ratio of death of 0.187 (P  .0001) compared with
those with three or more comorbidities, while those with
two comorbidities had an odds ratio of 0.362 (P 
.0001) compared with the reference.
The inclusion of gender in the model did not change
any of the inferences and was itself insignificant (P 
.7715). Female gender had an odds ratio of death of 0.948
compared with men when controlling for the covariates
above. Non-white race (black and “other”) had a higher
odds of death after CEA than whites when controlling for
other factors, but this relationship was non-significant.
Mortality rates for each volume group are shown in
Table II, and cross-tabulation of mortality rates for sub-
groups of surgeon volume categories within hospital vol-
ume categories are shown in Table III. These tables include
cumulative numbers of surgeons and CEAs over the 10-
year study.
DISCUSSION
In this analysis of predictors of death for 22,772 CEAs
with surgeon identifiers performed over 10 years in Mary-
land, the following covariates were found to be significant:
1) Each additional annual procedure for surgeons perform-
ing four to 15 CEAs per year (odds ratio 0.935, P .013);
2) Each additional annual procedure for hospitals perform-
ing 130 CEAs per year (odds ratio 0.945, P  .013);
3) Each additional year of age 60 (odds ratio 1.058, P 
.0001); 4) One Charlson comorbidity (odds ratio of 0.187
compared with three or more Charlson comorbidities, P
.0001); 5) Two Charlson comorbidities (odds ratio of
0.362 compared with three or more Charlson comorbidi-
ties, P  .0001).
refere
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of an event occurring in one group to the odds of it
occurring in another group. Generally speaking, odds rep-
resent the probability (p) of an event occurring to the
probability of it not occurring: odds (p 1 p ). Thus an
odds ratio of 1 indicates that an outcome (in-hospital death
after CEA in this study) is equally likely between two
groups. Logistic regression, employed here, provides odds
ratios per unit change in the predictor. Thus an estimated
odds ratio of 0.935 for CEA annual volume four to 15
means that a patient undergoing CEA by a surgeon per-
forming five CEAs annually would have 0.935 the odds of
in-hospital death compared with his odds of death should
Table I. Odds ratios of death following CEA for predicto
Predictor Odds ratio of death
Surgeon Volume 3* 0.802
Surgeon Volume 4-15* 0.935
Surgeon Volume 15* 0.997
Hospital Volume 130* 0.998
Hospital Volume 130* 0.945
Age 60

0.936
Age 60

1.058
1 Charlson Comorbidity

0.187
2 Charlson Comorbidities

0.362
3 Charlson Comorbidities

Reference
*Odds ratio of death per additional procedure per year within volume categ
Odds ratio of death per additional year of age within age category.
Odds ratio of death for number of Charlson comorbidities compared with
Table II. Number of surgeons and hospitals in different v
deaths
Volume category
Number in category
(percent)
Surgeon volume 1 214 (48.4)
Surgeon volume 3 60 (13.6)
Surgeon volume 4-15 109 (24.7)
Surgeon volume 15 59 (13.4)
Hospital Volume 130 45 (95.7)
Hospital Volume 130 2 (4.3)
Table III. Numbers of surgeons within hospital categorie
Hospital volume category Surgeon volume category
Numb
(
Hospital volume 130 4
Surgeon volume 1 19
Surgeon volume 3 5
Surgeon volume 4-15 9
Surgeon volume 15 5
Hospital volume 130
Surgeon volume 1 1
Surgeon volume 3
Surgeon volume 4-15 1
Surgeon volume 15he have had a surgeon performing four CEAs annually,other covariates being equal. This difference may appear
small at first glance, but magnifies as one compares slightly
different annual surgeon volumes. To compare the odds of
death for undergoing CEA by a surgeon performing nine
CEAs per year to one performing four CEAs per year, one
exponentiates the odds ratio: 0.9355  0.715. Therefore,
when accounting for age, hospital annual volume, and
comorbidities, the same patient undergoing CEA by a
surgeon performing nine CEAs annually would be ex-
pected to have less than ¾ the risk of death compared with
the risk should she undergo the surgery by a surgeon
performing four CEAs annually.
The decrease in the odds of death per additional annual
luded in the model
95% Confidence limits P value
0.505 1.275 .351
0.887 0.986 .013
0.987 1.006 .485
0.993 1.004 .563
0.904 0.998 .013
0.863 1.016 .115
1.030 1.088 <.0001
0.109 0.322 <.0001
0.232 0.566 <.0001
nce of 3.
e categories, with corresponding numbers of CEAs and
Number of CEAs in category
(percent)
Number of deaths
(mortality rate)
248 (1.1) 5 (2.0)
447 (2.0) 7 (1.6)
5,729 (25.2) 42 (0.7)
16,348 (71.8) 69 (0.4)
19,749 (86.7) 119 (0.6)
3,023 (13.3) 4 (0.1)
th corresponding numbers of CEAs and deaths
category
nt)
Number of CEAs in category
(percent)
Number of deaths
(mortality rate)
5.7) 19,749 (86.7) 119 (0.6)
9.0) 230 (1.2) 5 (2.2)
3.6) 417 (2.1) 7 (1.7)
4.3) 5,099 (25.8) 41 (0.8)
3.1) 14,003 (70.9) 66 (0.5)
.3) 3023 (13.3) 4 (0.1)
2.1) 18 (0.6) 0 (0.0)
3.2) 30 (1.0) 0 (0.0)
9.0) 630 (20.8) 1 (0.2)
5.8) 2,345 (77.6) 3 (0.1)rs inc
ory.olums, wi
er in
perce
5 (9
8 (4
5 (1
8 (2
3 (1
2 (4
6 (4
5 (1
1 (2surgeon procedure differs depending on the volume range.
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cedure is even more pronounced for annual surgeon vol-
umes less than or equal to three. The odds ratio supported
by our data for this volume range is 0.802, although this
did not achieve statistical significance (P  .351).
A similar effect was seen in analysis of the effect of
annual hospital volumes on the odds of death, but only in
high volume centers. For the majority of hospitals in the
database (those with annual CEA volume 130), the vol-
ume effect was exceedingly small and statistically non-
significant per additional annual procedure (odds ratio
0.998, P  .563). However, a statistically significant vol-
ume effect was seen in higher-volume centers, those per-
forming 130 CEAs per year. In these higher volume
centers, the odds ratio of death per additional procedure
was 0.945, P .013. As before, this effect amplifies when
considering large differences in annual volume within the
range: a patient undergoing surgery at a center performing
150 CEAs per year would have an odds of death of 0.94520
or 0.323 compared with undergoing surgery at a center
that saw 130 CEAs per year. However, this finding should
be interpreted with caution. There were very few centers
with130 annual CEAs included in this dataset and there-
fore these findings may not be generalizable. Observed
differences in the odds of death could be due to center-
specific factors, rather than annual CEA volume. In spite of
the suggestion of an inflection point around 25 CEAs per
year on the hospital volume spline, no knots in this range
were found to be significant. Thus the apparent rise in slope
for the smoothed log odds of death in the low volume
hospital range was not substantiated in likelihood ratio
analysis. Although previous studies have found profound
volume-outcome effects for hospital volume, they may not
have controlled for surgeon volume as we did in this
analysis. Similarly, our findings for high-volume surgeons
are limited by the smaller number of providers in the upper
ranges annual volume. Of note, there were 59 surgeons
over the 10-year study (13.4% of our sample) in our cate-
gory of 15 CEAs per year. Analysis of the effect on odds
of death of an additional procedure per year for this group
did not yield a statistically significant effect (P .485). It is
possible that a larger sample size in this volume category
could have rendered this effect significant. It is notable,
however, that for both surgeons and hospitals, higher
annual volume was always predictive of lower odds of
death, even if the inference did not attain statistical signif-
icance. In no case did we find higher odds of death with
higher annual CEA volume.
We found a U-shaped relationship for odds of death
relative to age in this study. Each additional year of age in
patients 60 years led to a decreased risk of death but did
not attain statistical significance (odds ratio 0.936, P 
.115). However, in patients60 years, each additional year
contributed to the odds of death after CEA (odds ratio
1.058, P .0001). We expect this U-shaped relationship is
due to different risk profiles in the young undergoing CEA
compared with those of advanced age. Young patientsundergoing CEA may have risks that were not captured by
our efforts to control for comorbidity in this analysis.
Finally, the presence of comorbidities proved to be
highly significant in contributing to risk of in-hospital
death following CEA. We used3 Charlson comorbidities
as the reference group, and compared the odds of death for
patients with one or two comorbidities. After controlling
for annual surgeon volume, hospital volume and age (60
years versus 60 years), patients with only one Charlson
comorbidity were found to have less than 20% of the odds
of death compared with those with3 comorbidities (odds
ratio 0.187, P  .0001). Patients with two Charlson co-
morbidities had 0.362 the odds of death compared with the
reference group (P  .0001). This confirms the need for
careful patient selection for CEA.
The strengths of our study lie in its unique approach
compared with previous analyses of the volume-outcome
effect. We examined the data by inspection of logit-
transformed lowess smoothing functions for appropriate
cutoffs rather than using quantiles or empiric volume cate-
gories. By using the data itself to choose volume categories,
we avoided “fishing” for cutoffs rendering the lowest P
values, instead choosing the best combination of knots
based on log-likelihoods.
The weaknesses of our study mirror those with the use
of any secondary analysis of administrative data. We believe
the data source to be valid, based on previous corrobora-
tion with our institution’s CEA data.29 Nonetheless, as
with any administrative dataset, there is the potential for
non-differential or differential underreporting of events.
Non-differential underreporting would bias our findings
towards the null, whereas systematic, differential underre-
porting could change the direction or magnitude of the
effect. Another threat to internal validity of administrative
data includes confounding.35 Our data lacks information
on surgeon or hospital characteristics, which could act as
unmeasured confounders in the relationship between CEA
annual volume and in-hospital death. For instance, our data
contains no information on specialty training, years in
practice, or other factors that could contribute to technical
expertise. The high number of surgeons performing a
single CEA annually (214 unique practitioners over the
10-year study, or 48.4%) begs the question of whether
these “surgeons” in fact represent referral physicians or
trainees. We feel this is unlikely, given our requirement of
the presence of Diagnosis Related Group 5 in our case
identification algorithm. Given the ghost coding of physi-
cians in the Maryland HSCRC database, it is not possible to
know the board certification or fellowship training status of
the providers and it therefore remains possible that some
non-surgeons or trainees were captured in our analysis.
Additionally, although we used the HSCRC database
for 10 years and identified 22,772 patients who underwent
CEA, the database included only 123 deaths. This low
number of events may have limited our ability to detect
statistically significant differences. Our analysis is limited by
the inability to differentiate deaths attributable directly to
CEA from those related to underlying medical conditions.
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pulmonary embolism or arrhythmia. The use of a more
common complication such as post-CEA stroke would
have provided a larger number of events and a more rele-
vant volume-outcome relationship.
We chose to control for patient comorbidity using
those conditions identified by Charlson because this
method remains the most widely used, and has been vali-
dated in multiple languages and for other diseases. How-
ever, Elixhauser has developed a method with some
strengths over the Charlson approach, by capturing acute
illnesses, adding a number of comorbidities, and dropping
others that seemed conceptually inappropriate.36 We also
did not use the weights included in the original Charlson
Index, as we did not want to assume that these weights
derived from Charlson’s set of medical patients would apply
to the surgical patients in our dataset. Of perhaps more
relevance, the Maryland HSCRC database lacks present-
on-admission coding. It is therefore possible that some
comorbidities may in fact represent complications of the
CEA itself. Despite these limitations, we feel that our
approach remains a reasonable method to provide some
measure of control over comorbidities in this study dem-
onstrating a rigorous statistical treatment of the volume-
outcome effect. We elected to control for comorbidity
rather than symptomatic status as methods for comorbidity
adjustment are well-validated, whereas those for identifica-
tion of symptomatic status are not. Previous work from our
group has demonstrated that the overwhelming majority of
patients undergoing CEA today in Maryland, as elsewhere,
are asymptomatic. This is consistent with the preponder-
ance of asymptomatic patients treated in most of the very
recent carotid stent trials and registries.
We have demonstrated a technique for rigorous statis-
tical analysis of volume-outcome data and have found a
modest volume effect for death after CEA in this 10-year
dataset from Maryland after controlling for patient comor-
bidities and age. Higher volume surgeons had lower esti-
mated odds of death, particularly when considering those
performing four to 15 CEAs per year. These data suggest
that a patient undergoing CEA by a surgeon performing an
average of 16 CEAs annually has a statistically equivalent
risk of death compared with one undergoing CEA by a
surgeon performing any number higher than this, when
controlling for hospital volume, patient comorbidity, and
patient age. Hospital volume was not seen to be as signifi-
cant a predictor of post-operative death in this study, with
only high volume hospitals (130 CEAs per year) showing
a statistically significant decrease in the estimated odds ratio
of death. Patient comorbidity was a significant predictor of
in-hospital post-operative death even after controlling for
surgeon and hospital volume and patient age, confirming
the need for careful patient selection for CEA. As studies on
volume-outcome relationships can have important implica-
tions for health policy and surgical training, such studies
should consider non-linear effects in their modeling of
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Timothy F. Kresowik, MD, Iowa City, Iowa
Dr. Nazarian and her colleagues have provided an elegant
statistical analysis of the carotid endarterectomy (CEA) volume/
outcome effect on mortality using a hospital administrative data-
base. Unfortunately, administrative databases are derived from
hospital claims which are focused on payment and are of only
limited utility for outcome studies. The capture of procedure
indication, comorbid conditions, and complications may be in-
complete or inaccurate. The inability to accurately stratify CEA
patients by indication or validly capture postoperative stroke is an
important limitation.
The striking finding that approximately half the surgeons
(214/442) in Maryland are performing one or fewer CEA proce-
dures a year is potentially more suggestive of a problem with the
database than necessarily an accurate representation of practice.
The database is derived from hospital claims not those of the
surgeon. The data field used to determine the physician of record
for the hospital stay could have non-surgeons (eg primary care
physicians or hospitalists) in that field. Acceptance of this finding
requires additional validation.
It is hard to argue against the concept that experience with agate for experience and even more importantly judgment. Is an-
nual volume as good a predictor for the surgeon who has had
adequate vascular training and practices 100% vascular surgery, but
with a relatively low volume of CEA procedures, as for the surgeon
without vascular training whose only vascular procedure is an
occasional CEA? These are important questions that are not an-
swered in this study.
I would argue that the perverse incentives associated with
using an annual procedure volume threshold alone to direct pay-
ment policy are likely to result in more harm than benefit. Over-
emphasis on procedure volume creates an incentive to do proce-
dures rather than counsel patients adequately about the risks versus
benefits of that procedure. In any study that has large numbers, it
is important to recognize that statistical significance does not
indicate the magnitude of the effect. In the current study, the
mortality of CEA for the group of surgeons who did four to 14
procedures a year was 0.7% versus 0.4% for the surgeons who did
15 or more. The benefit of carotid intervention in asymptomatic
patients is not high. Any policy that creates more incentive for the
potential overuse of carotid intervention in asymptomatic patients
is likely to cause more population harm than any benefit accrued
from this small absolute decrease in mortality.
